Nika Pharmaceuticals, Inc (NIKA) Total Current Liabilities (2021 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly Total Current Liabilities came in at $18180.0 in Q4 2023, little changed YoY from $18180.0 in Q4 2022, and down 78.8% on a QoQ basis from $85745.0 in Q3 2023.
Nika Pharmaceuticals, Inc (NIKA) Total Current Liabilities (2021 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 3 years of Total Current Liabilities data on file, last reported at $18180.0 in Q4 2023.
- Quarterly Total Current Liabilities changed 0.0% year-over-year to $18180.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $18180.0 (changed 0.0% YoY) and the FY2023 annual result came in at $18180.0, changed 0.0% from the prior year.
- Total Current Liabilities eased to $18180.0 in Q4 2023, from $85745.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $85745.0 in Q3 2023 to a low of $4472.0 in Q2 2022.
- A 3-year average of $32545.6 and a median of $18180.0 in 2022 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 1593.76% in 2023, down 0.0% in 2023.
- Tracing NIKA's Total Current Liabilities over 3 years: stood at $10518.0 in 2021, then surged by 72.85% to $18180.0 in 2022, then changed by 0.0% to $18180.0 in 2023.
- The last three Total Current Liabilities figures came in at $18180.0 (Q4 2023), $85745.0 (Q3 2023), and $75745.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 18,180.00 |
| Sep 30, 2023 | 85,745.00 |
| Jun 30, 2023 | 75,745.00 |
| Mar 31, 2023 | 41,345.00 |
| Dec 31, 2022 | 18,180.00 |
| Sep 30, 2022 | 6,180.00 |
| Jun 30, 2022 | 4,472.00 |
| Dec 31, 2021 | 10,518.00 |